28 Apr 2020

Technopath Clinical Diagnostics USA awarded Quality Control material agreement with Premier Inc.

Technopath Clinical Diagnostics USA and Premier Inc. logos

Technopath Clinical Diagnostics USA has been awarded a group purchasing agreement for Quality Control material with Premier Inc (Premier). Effective April 1, 2020, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Quality Control material.

Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,000 U.S. hospitals and 175,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.


About Technopath Clinical Diagnostics

Technopath Clinical Diagnostics (Technopath) is a global leader in the development and manufacture of total quality control (QC) solutions for clinical laboratories. Technopath launched the IVD industry’s first truly consolidated Immunochemistry Quality Control materials. Consolidating multiple tests into one QC product enables clinical laboratories to significantly improve the efficiency and cost effectiveness of QC processes. Their IAMQC® Infinity program automates the handling and management of QC data, while facilitating laboratory accreditation requirements. Technopath's QC and informatics products are used by leading laboratories in over 130 countries globally.

For more information on Technopath’s portfolio of QC Data Management Solutions and Quality Controls supporting laboratory efficiencies please contact info@technopathusa.com.